A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2004
12/29/2004	CA2526563A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/29/2004	CA2526099A1 Freeze-dried fsh / lh formulations
12/29/2004	CA2524739A1 Metronidazole-based green tinted topical pharmaceutical composition
12/29/2004	CA2524256A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same
12/28/2004	US6835807 Drug complex and drug delivery system
12/28/2004	US6835722 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
12/28/2004	US6835718 Biocleavable micelle compositions for use as drug carriers
12/28/2004	US6835712 Compounds
12/28/2004	US6835536 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a
12/28/2004	US6835401 Method of treating diseases caused by over-production of free-radicals
12/28/2004	US6835396 Energizing a multiphase system having an organic phase containing a poorly water soluble compound, e.g. drug, and an aqueous phase to form a fine dispersion; freeze drying; particularly for intravenous injection
12/28/2004	US6835393 Enhanced transport using membrane disruptive agents
12/28/2004	US6835392 Dual enhancer composition for topical and transdermal drug delivery
12/28/2004	US6835390 Method for producing tissue engineered meat for consumption
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	US6835194 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
12/28/2004	CA2287534C Biodegradable microparticles for the sustained delivery of therapeutic drugs
12/28/2004	CA2248368C Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents
12/28/2004	CA2128103C Formulation and use of carotenoids in treatment of cancer
12/23/2004	WO2004111192A2 Targeted delivery to legumain-expressing cells
12/23/2004	WO2004110585A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
12/23/2004	WO2004110498A2 Drug conjugate composition
12/23/2004	WO2004110497A2 Mitomycin conjugates cleavable by thiols
12/23/2004	WO2004110494A1 Compositions for treating infection in cattle and swine
12/23/2004	WO2004110445A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa
12/23/2004	WO2004110423A1 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/23/2004	WO2004110420A1 Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
12/23/2004	WO2004110403A1 Transnasal microemulsions containing diazepam
12/23/2004	WO2004110398A1 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
12/23/2004	WO2004110392A2 Compositions and methods for treating coronavirus infection and sars
12/23/2004	WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004	WO2004110358A2 Polymeric conjugates for tissue activated drug delivery
12/23/2004	WO2004110337A2 Cell permeable conjugates of peptides for inhibition of protein kinases
12/23/2004	WO2004110270A1 Directing cells to target tissues or organs
12/23/2004	WO2004110255A2 Antineoplastic agents targeted via glut transporters
12/23/2004	WO2004087759A3 Method and compositions for conversion of antibody activity
12/23/2004	WO2004087121A3 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
12/23/2004	WO2004085386A3 Heterobifunctional polymeric bioconjugates
12/23/2004	WO2004083251A3 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
12/23/2004	WO2004082588A3 Dispersible formulation of an anti-inflammatory agent
12/23/2004	WO2004078142A3 Compositions and methods for preventing and treating endotoxin-related diseases and conditions
12/23/2004	WO2004069032A3 Viscous swallow medium and method of use for esophageal function testing
12/23/2004	WO2004054541A3 Ketoprofen compositions and methods of making them
12/23/2004	WO2004049917A3 Methods of therapy and diagnosis using targeting of cells that express ly-9
12/23/2004	WO2003097805A3 Delivery of nucleic acid-like compounds
12/23/2004	WO2003000237A8 Biodegradable polymer coompositions
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260115 Polymers for the delivery of bioactive agents and methods of their preparation
12/23/2004	US20040259954 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
12/23/2004	US20040259952 Formulations for oral administration of cromolyn sodium
12/23/2004	US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
12/23/2004	US20040259905 stable, less irritant and easily administrable; high concentration of sulfodehydroabietic acid or salt ion at pH of 7-8.5 in a buffer of a polyphosphate salt or polycarboxylic acid salt such as trisodium citrate and an inorganic base such as sodium hydroxide; for inflammatory bowel disease treatment
12/23/2004	US20040259837 Modification of solid 3-sn-phosphoglycerides
12/23/2004	US20040259835 Stabilized brivudine topical formulations
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259796 Using a peptide
12/23/2004	US20040259786 Method of transporting a chimeric hybrid molecule across the blood brain barrier
12/23/2004	US20040259768 Deactivable compound produced by target cell; diagnosis, therapy disease
12/23/2004	US20040258826 Matrix-forming composition containing pectin
12/23/2004	US20040258801 Vitamin fortification of foodstuffs
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258771 Reduced toxicity cisplatin formulations and methods for using the same
12/23/2004	US20040258762 Microparticle of crosslinked protein shell with amine, hydroxyl, carboxylate and/or sulfhydryl moitey covalently bonded to surface coating of polyoxyethylene glycol
12/23/2004	US20040258761 Dissolving a biocompatible, biodegradable polymer in solution comprising sublimable substance and an oil phase; emulsification, pouring into surfactant solution to breaking; shrinkage, washing; enhancement during ultrasound; tumors
12/23/2004	US20040258760 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
12/23/2004	US20040258757 Liquid dosage compositions of stable nanoparticulate active agents
12/23/2004	US20040258755 Dissolved cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(alkanoyloxy)]platinum(II) in 2-methyl-2-propanol; stabile, easily handled injection; fine, homogenous suspension; controlled particle size distribution
12/23/2004	US20040258753 Exterior semipermeable memrane wherein bio-agent release or delivery is caused by explosion of membrane and begins after a lag time; and core contains bio-agent and biodegradable oligomer or polymer aqueous solution; time-release agents; drugs, proteins, vitamins, hormones, biocides, pesticides
12/23/2004	US20040258749 Side effect reduction; retarder coating; embedded in matrix; sustained release
12/23/2004	US20040258748 Compressing mixture of drug and effervescent acid source and base to produce a tablet; moisture activation; disintegration; drugs such as rofecoxib, simvastatin, olanzapine; and sodium bicarbonate
12/23/2004	US20040258745 Pharmaceutical composition containing artificial oxygen carrier
12/23/2004	US20040258741 Percutaneous absorption preparations
12/23/2004	US20040258740 Transdermal delivery composition
12/23/2004	US20040258739 Plaster for the treatment of dysfunctions and disorders of nails
12/23/2004	US20040258733 Dentifrice, chewing gum, confection, lozenge, mouthwash, mouth spray or edible film; bactericides; food acid, anticaries agent, antitartar agent, softener, plasticizer, essential oil, emulsifiers
12/23/2004	US20040258725 Nontoxic pesticide, and method of using the same
12/23/2004	US20040258724 Gilsonite oil and drug for topical or transdermal drug delivery to skin or nails; penetration ehancement
12/23/2004	US20040258722 Water in oil- or oil in water emulsion with glycerol or sorbitol polyol; suncreen agents, creams, lotions; reduced adhesion of sand particles
12/23/2004	US20040258718 Synergistic mixed poloxamer systmes for the solubilisation of drugs
12/23/2004	US20040258717 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of the healthy-skin
12/23/2004	US20040258716 Spill-resistant, semi-solid, aqueous pharmaceutical suspension for oral administration comprising a water-insoluble medicine in a stabilizing vehicle of glycerin, sorbitol, propylene glycol and thickener, e.g. Carbopol"; palatable; homogeneous; shelf life of <36 months; crystal growth inhibitors
12/23/2004	US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy
12/23/2004	US20040258700 A nontoxic mixture of 2-phenoxyethanol and para hydroxybenzoates, (e.g. methyl-, ethyl-, propyl- or butyl-, p-hydroxybenzoate) more effective than 2-phenoxyethanol alone (mixture, called TF-1); effect comparable to that of thiomersal or chloroform in vaccines
12/23/2004	US20040258698 Delivery of immune response modifier compounds
12/23/2004	US20040258693 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC
12/23/2004	US20040258688 Long lasting immunity using single dose at low concentration; exposing dendritic cells to antigen-antibody-DEC-205 receptor conjugate or to recombinant anti-DEC-205 antibody and promoting maturation
12/23/2004	US20040258683 Administering epitope that maintains sustained reduction of circulating anti-dsDNA antibodies; reducing risk of renal flare
12/23/2004	US20040258677 Suppressing immune response; providing tolerance to amino acid sequences different than host
12/23/2004	US20040258675 Novel mutated form of arginine deiminase
12/23/2004	US20040258665 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
12/23/2004	US20040258660 Tumor necrosis factor alpha analogues having three dimensional structure of similar to proteins from which they are derived; facilitating correct folding
12/23/2004	US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics
12/23/2004	US20040258647 Active ingredient-containing cosmetic cleansing emulsions
12/23/2004	US20040258626 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler
12/23/2004	US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants
12/23/2004	US20040258620 In vivo stability, biocompatibility, organ specificity; low dosage, rapid excretion; nuclear magnetic resonance diagnostic imaging, radiotherapy
12/23/2004	US20040258619 Diaminedioxime radiometal complexes

1 ... 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 ... 1712